Credit Suisse’s Vicarious Surgical RBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Hold
0
-$4 3628
2022
Q4
Sell
-10
Closed -$930 3847
2022
Q3
$1K Buy
10
+1
+11% +$117 ﹤0.01% 3907
2022
Q2
$1K Buy
+9
New +$1.1K ﹤0.01% 3833
2021
Q4
Sell
-1,019
Closed -$457K 4647
2021
Q3
$457K Buy
+1,019
New +$323K ﹤0.01% 3860

Other funds holding RBOT

Credit Suisse's RBOT Position: Q1 2023 in Review

Credit Suisse held its Vicarious Surgical (RBOT) position steady in Q1 2023 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3628.

Credit Suisse first reported a position in RBOT in Q3 2021 and has held it in 3 quarters since. The position peaked at $457K in Q3 2021. 79 funds tracked by Wall St. Rank hold RBOT as of Q1 2023.

  • Credit Suisse held 0 shares of Vicarious Surgical worth $0 as of Q1 2023.
  • Credit Suisse left its Vicarious Surgical share count unchanged in Q1 2023.
  • Vicarious Surgical made up ﹤0.01% of Credit Suisse's portfolio in Q1 2023, its #3628 holding.
  • Credit Suisse first reported a position in Vicarious Surgical in Q3 2021 and has held it in 3 quarters since.
  • Credit Suisse's Vicarious Surgical position peaked at $457K in Q3 2021.
  • 79 funds tracked by Wall St. Rank held Vicarious Surgical as of Q1 2023.

Based on Credit Suisse's 13F filing for Q1 2023, filed 10 May 2023.